358 related articles for article (PubMed ID: 9935253)
21. Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in humans.
Vincent J; Dogolo L; Baris BA; Willavize SA; Teng R
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):427-30. PubMed ID: 9758287
[TBL] [Abstract][Full Text] [Related]
22. An Open-Label, Randomized Bioavailability Study of Alternative Methods of Oral Administration of Naloxegol in Healthy Subjects.
Bui K; Birmingham B; Diva U; Berger B
Clin Pharmacol Drug Dev; 2017 Jul; 6(4):420-427. PubMed ID: 28127938
[TBL] [Abstract][Full Text] [Related]
23. Effect of Maalox and omeprazole on the bioavailability of trovafloxacin.
Teng R; Dogolo LC; Willavize SA; Friedman HL; Vincent J
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():93-7. PubMed ID: 9222077
[TBL] [Abstract][Full Text] [Related]
24. Penetration of trovafloxacin into gynecologic tissues.
Martens MG; Maccato M; Van Hook C; Vincent J
Am J Surg; 1998 Dec; 176(6A Suppl):18S-22S. PubMed ID: 9935252
[TBL] [Abstract][Full Text] [Related]
25. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C
Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and metabolism of single oral doses of trovafloxacin.
Vincent J; Teng R; Dalvie DK; Friedman HL
Am J Surg; 1998 Dec; 176(6A Suppl):8S-13S. PubMed ID: 9935250
[TBL] [Abstract][Full Text] [Related]
27. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
28. A pharmacokinetic and pharmacodynamic comparison of desmopressin administered as whole, chewed and crushed tablets, and as an oral solution.
Argenti D; Ireland D; Heald DL
J Urol; 2001 May; 165(5):1446-51. PubMed ID: 11342894
[TBL] [Abstract][Full Text] [Related]
29. Hepatobiliary elimination of trovafloxacin and metabolites following single oral doses in healthy volunteers.
Melnik G; Schwesinger WH; Teng R; Dogolo LC; Vincent J
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):424-6. PubMed ID: 9758286
[TBL] [Abstract][Full Text] [Related]
30. Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacin.
Williams DJ; Hopkins S
Am J Surg; 1998 Dec; 176(6A Suppl):74S-79S. PubMed ID: 9935261
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Crushed Tablet for Oral Administration and the Effect of Food on Apixaban Pharmacokinetics in Healthy Adults.
Song Y; Chang M; Suzuki A; Frost RJ; Kelly A; LaCreta F; Frost C
Clin Ther; 2016 Jul; 38(7):1674-1685.e1. PubMed ID: 27292282
[TBL] [Abstract][Full Text] [Related]
32. A Pharmacokinetic Study Comparing Eslicarbazepine Acetate Administered Orally as a Crushed or Intact Tablet in Healthy Volunteers.
Sunkaraneni S; Kharidia J; Schutz R; Blum D; Cheng H
Clin Pharmacol Drug Dev; 2016 Jul; 5(4):278-84. PubMed ID: 27249205
[TBL] [Abstract][Full Text] [Related]
33. Bioequivalence of ximelagatran, an oral direct thrombin inhibitor, as whole or crushed tablets or dissolved formulation.
Schützer KM; Wall U; Lönnerstedt C; Ohlsson L; Teng R; Sarich TC; Eriksson UG
Curr Med Res Opin; 2004 Mar; 20(3):325-31. PubMed ID: 15025841
[TBL] [Abstract][Full Text] [Related]
34. Phase I pilot study of the effects of trovafloxacin (CP-99,219) on the pharmacokinetics of theophylline in healthy men.
Dickens GR; Wermeling D; Vincent J
J Clin Pharmacol; 1997 Mar; 37(3):248-52. PubMed ID: 9089427
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and absolute bioavailability of ciprofloxacin administered through a nasogastric tube with continuous enteral feeding to critically ill patients.
Mimoz O; Binter V; Jacolot A; Edouard A; Tod M; Petitjean O; Samii K
Intensive Care Med; 1998 Oct; 24(10):1047-51. PubMed ID: 9840238
[TBL] [Abstract][Full Text] [Related]
36. Comparative pharmacokinetics of voriconazole administered orally as either crushed or whole tablets.
Dodds Ashley ES; Zaas AK; Fang AF; Damle B; Perfect JR
Antimicrob Agents Chemother; 2007 Mar; 51(3):877-80. PubMed ID: 17145785
[TBL] [Abstract][Full Text] [Related]
37. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
Ahmad M; Pervaiz F
Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
[TBL] [Abstract][Full Text] [Related]
38. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
Bramer SL; Forbes WP
Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
[TBL] [Abstract][Full Text] [Related]
39. Esomeprazole administered through a nasogastric tube provides bioavailability similar to oral dosing.
Sostek MB; Chen Y; Skammer W; Winter H; Zhao J; Andersson T
Aliment Pharmacol Ther; 2003 Sep; 18(6):581-6. PubMed ID: 12969084
[TBL] [Abstract][Full Text] [Related]
40. Brief Report: Pharmacokinetics of Crushed Elvitegravir Combination Tablet Given With or Without Enteral Nutrition.
Jongbloed-de Hoon M; Colbers A; Velthoven-Graafland K; Duisenberg-van Essenberg M; Kruijssen M; Abbink E; van Crevel R; Burger D
J Acquir Immune Defic Syndr; 2017 Apr; 74(5):571-574. PubMed ID: 28166190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
